Roche's glofitamab Phase 2 trial in untreated DLBCL posts results after primary completionAug 18Trial updateglofitamabprednisone
ADC Therapeutics reweighs ZYNLONTA path after FDA raises LOTIS-5 safety concernsAug 13Regulatory decisionADC Therapeutics SAloncastuximab tesirine
Arvinas reports Q2 2026 results after first-ever FDA approval of a PROTAC drugAug 4Quarterly updateArvinas Inc.
BMS trials post results across lung cancer, sarcoma, myelofibrosis; new stroke study opensJul 17Weekly roundup, 5 itemsBristol Myers Squibblisocabtagene maraleucel
Sign inSign in